Axonics Inc (AXNX)

$70.98 +0.53 (0.75%)
Market Cap 3.63B
Revenue (ttm) 366.38M
Net Income (ttm) -6.09M
EPS (ttm) N/A
PE Ratio 1,761.25
Forward PE 325.10
Profit Margin -1.66%
Debt to Equity Ratio 0.00
Volume 4,233,300
Avg Vol 503,424
Day's Range N/A - N/A
Shares Out 51.11M
Stochastic %K 91%
Beta 0.82
Analysts Sell
Price Target $71.80
xMonti
xMonti Jan. 6 at 10:47 PM
$NARI After $AXNX , this was on radar. Looking at current GLP-1 demand , $VKTX $ALT
0 · Reply
NVDAMillionaire
NVDAMillionaire Dec. 1 at 2:18 PM
$AXNX Axonics, Inc. (NASDAQ:AXNX): A Pioneering Force in Bladder and Bowel Dysfunction Management https://beyondspx.com/article/axonics-inc-nasdaq-axnx-a-pioneering-force-in-bladder-and-bowel-dysfunction-management
0 · Reply
TwongStocks
TwongStocks Nov. 14 at 8:07 PM
$AXNX At a special meeting held on March 22, 2024 the shareholders of Axonics, Inc. (AXNX) approved a merger with Boston Scientific Corp (BSX) . The merger is tentatively scheduled to close prior to the market open on November 15, 2024. In anticipation of the closing, the stock will be halted immediately following the after-hours session at or around 7:50 p.m. on November 14, 2024. If the merger closes as anticipated, the stock will remain halted on the day of closing (November 15th) and will be suspended effective November 18, 2024 https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2024-557
0 · Reply
PenkeTrading
PenkeTrading Nov. 5 at 12:27 PM
I found you an Overbought RSI (Relative Strength Index) on the daily chart of Axonics Modulation Technologies Inc. Is that bullish or bearish? $AXNX #RsiOverbought #NASDAQ
1 · Reply
WeeklyTrader
WeeklyTrader Oct. 23 at 11:08 AM
Climbing higher with $AXNX! RSI: 68.7% 50-day MA: $69.34 200-day MA: $68.19
0 · Reply
WeeklyTrader
WeeklyTrader Oct. 15 at 6:09 PM
Riding the momentum wave! Buy a CALL on $AXNX at strike None! RSI: 69.78% 50-day MA: $69.13 200-day MA: $67.87
0 · Reply
WeeklyTrader
WeeklyTrader Oct. 13 at 7:44 AM
Who’s looking for the exits with $AXNX? RSI: 72.82% 50-day MA: $69.1 200-day MA: $67.83
0 · Reply
WeeklyTrader
WeeklyTrader Oct. 12 at 11:03 PM
Who's planning to sell $AXNX? RSI: 72.82% 50-day MA: $69.1 200-day MA: $67.83
0 · Reply
insiderbuyingselling
insiderbuyingselling Oct. 4 at 1:54 AM
$AXNX new insider selling: 2961 shares. http://insiderbuyingselling.com/?t=AXNX
0 · Reply
Stock_Titan
Stock_Titan Sep. 26 at 10:00 AM
$AXNX Axonics Receives Regulatory Approval for Fourth-Generation Rechargeable SNM System in Australia https://www.stocktitan.net/news/AXNX/axonics-receives-regulatory-approval-for-fourth-generation-3ovsgvazbyi0.html
0 · Reply
Latest News on AXNX
Boston Scientific Closes Acquisition of Axonics, Inc.

Nov 15, 2024, 8:43 AM EST - 8 months ago

Boston Scientific Closes Acquisition of Axonics, Inc.

BSX

Axonics Reports Third Quarter 2024 Financial Results

Nov 7, 2024, 4:01 PM EST - 8 months ago

Axonics Reports Third Quarter 2024 Financial Results

Axonics Receives Regulatory Approval for Fourth-Generation Rechargeable SNM System in Australia

Sep 26, 2024, 6:00 AM EDT - 10 months ago

Axonics Receives Regulatory Approval for Fourth-Generation Rechargeable SNM System in Australia

Axonics Prevails in Patent Infringement Lawsuit with Medtronic

Sep 18, 2024, 6:59 PM EDT - 10 months ago

Axonics Prevails in Patent Infringement Lawsuit with Medtronic

Axonics Reports Second Quarter 2024 Financial Results

Aug 1, 2024, 4:01 PM EDT - 1 year ago

Axonics Reports Second Quarter 2024 Financial Results

Axonics Receives Regulatory Approval for Recharge-Free SNM System in Australia

May 16, 2024, 4:01 PM EDT - 1 year ago

Axonics Receives Regulatory Approval for Recharge-Free SNM System in Australia

Axonics Reports First Quarter 2024 Financial Results

Apr 30, 2024, 4:01 PM EDT - 1 year ago

Axonics Reports First Quarter 2024 Financial Results

Boston Scientific Announces Results for First Quarter 2024

Apr 24, 2024, 6:30 AM EDT - 1 year ago

Boston Scientific Announces Results for First Quarter 2024

BSX

FTC seeks more information on Boston Scientific's $3.7 bln Axonics deal

Apr 4, 2024, 7:54 AM EDT - 1 year ago

FTC seeks more information on Boston Scientific's $3.7 bln Axonics deal

BSX

Axonics Stockholders Approve Merger Agreement with Boston Scientific

Mar 22, 2024, 4:01 PM EDT - 1 year ago

Axonics Stockholders Approve Merger Agreement with Boston Scientific

BSX

Axonics Provides Update on Inter Partes Review Proceedings

Mar 21, 2024, 4:54 PM EDT - 1 year ago

Axonics Provides Update on Inter Partes Review Proceedings

Axonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System

Mar 14, 2024, 6:00 AM EDT - 1 year ago

Axonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System

Axonics Responds to ITC Action by Medtronic

Feb 29, 2024, 4:01 PM EST - 1 year ago

Axonics Responds to ITC Action by Medtronic

Axonics Reports Fourth Quarter and Fiscal Year 2023 Financial Results

Feb 28, 2024, 4:01 PM EST - 1 year ago

Axonics Reports Fourth Quarter and Fiscal Year 2023 Financial Results

AXONICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Axonics, Inc. - AXNX

Feb 27, 2024, 3:30 PM EST - 1 year ago

AXONICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Axonics, Inc. - AXNX

BSX

Boston Scientific Announces Results for Fourth Quarter and Full Year 2023

Jan 31, 2024, 6:30 AM EST - 1 year ago

Boston Scientific Announces Results for Fourth Quarter and Full Year 2023

BSX

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Axonics, Inc.

Jan 8, 2024, 4:55 PM EST - 1 year ago

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Axonics, Inc.

BSX

Axonics Stock Soars. It's Being Acquired By Boston Scientific In $3.7 Billion Deal.

Jan 8, 2024, 8:18 AM EST - 1 year ago

Axonics Stock Soars. It's Being Acquired By Boston Scientific In $3.7 Billion Deal.

BSX

Boston Scientific To Acquire Axonics For About $3.7 Bln

Jan 8, 2024, 7:58 AM EST - 1 year ago

Boston Scientific To Acquire Axonics For About $3.7 Bln

BSX

Boston Scientific to buy Axonics for $3.7 billion

Jan 8, 2024, 7:09 AM EST - 1 year ago

Boston Scientific to buy Axonics for $3.7 billion

BSX

Boston Scientific Announces Agreement to Acquire Axonics, Inc.

Jan 8, 2024, 7:00 AM EST - 1 year ago

Boston Scientific Announces Agreement to Acquire Axonics, Inc.

BSX

Axonics Announces Definitive Agreement to be Acquired by Boston Scientific

Jan 8, 2024, 7:00 AM EST - 1 year ago

Axonics Announces Definitive Agreement to be Acquired by Boston Scientific

BSX

Axonics Reports Preliminary 4Q23 and Fiscal Year 2023 Revenue

Jan 8, 2024, 7:00 AM EST - 1 year ago

Axonics Reports Preliminary 4Q23 and Fiscal Year 2023 Revenue

Axonics to Present at the J.P. Morgan Healthcare Conference

Dec 27, 2023, 4:01 PM EST - 1 year ago

Axonics to Present at the J.P. Morgan Healthcare Conference

BiVACOR Appoints Veteran Medical Device Executive Raymond W. Cohen as Chairman of the Board of Directors

Dec 27, 2023, 8:00 AM EST - 1 year ago

BiVACOR Appoints Veteran Medical Device Executive Raymond W. Cohen as Chairman of the Board of Directors

Goldman Sachs money manager digs into three themes for long-term growth

Dec 5, 2023, 11:27 AM EST - 1 year ago

Goldman Sachs money manager digs into three themes for long-term growth

CAVA GSC IRTC MTH NVO SG SHAK

Axonics to Participate in November Investor Conferences

Nov 1, 2023, 6:00 AM EDT - 1 year ago

Axonics to Participate in November Investor Conferences

Axonics, Inc. (AXNX) Q3 2023 Earnings Call Transcript

Oct 30, 2023, 10:15 PM EDT - 1 year ago

Axonics, Inc. (AXNX) Q3 2023 Earnings Call Transcript

Axonics Reports Third Quarter 2023 Financial Results

Oct 30, 2023, 4:01 PM EDT - 1 year ago

Axonics Reports Third Quarter 2023 Financial Results

Axonics to Report Third Quarter 2023 Financial Results on October 30

Oct 2, 2023, 6:00 AM EDT - 1 year ago

Axonics to Report Third Quarter 2023 Financial Results on October 30

Axonics: Growing Duopolist With Superior Product And No Debt

Sep 7, 2023, 8:27 AM EDT - 2 years ago

Axonics: Growing Duopolist With Superior Product And No Debt

Axonics to Participate in September Investor Conferences

Aug 25, 2023, 6:00 AM EDT - 2 years ago

Axonics to Participate in September Investor Conferences

Axonics Announces CFO Retirement and Appoints Successor

Aug 21, 2023, 6:00 AM EDT - 2 years ago

Axonics Announces CFO Retirement and Appoints Successor

Axonics, Inc. (AXNX) Q2 2023 Earnings Call Transcript

Jul 27, 2023, 11:27 PM EDT - 2 years ago

Axonics, Inc. (AXNX) Q2 2023 Earnings Call Transcript

Axonics Reports Second Quarter 2023 Financial Results

Jul 27, 2023, 4:01 PM EDT - 2 years ago

Axonics Reports Second Quarter 2023 Financial Results

July MDA Breakout Stocks Week 29 - 2023: High-Frequency Gainers To Give You An Edge

Jul 17, 2023, 5:36 AM EDT - 2 years ago

July MDA Breakout Stocks Week 29 - 2023: High-Frequency Gainers To Give You An Edge

AAPL ASAN BFLY CELH CSCO DHI ENPH

Axonics to Report Second Quarter 2023 Financial Results on July 27

Jun 29, 2023, 6:00 AM EDT - 2 years ago

Axonics to Report Second Quarter 2023 Financial Results on July 27

Axonics: Q1 Fall Provides Great Entry Point

May 4, 2023, 6:22 AM EDT - 2 years ago

Axonics: Q1 Fall Provides Great Entry Point

Axonics, Inc. (AXNX) Q1 2023 Earnings Call Transcript

May 1, 2023, 9:36 PM EDT - 2 years ago

Axonics, Inc. (AXNX) Q1 2023 Earnings Call Transcript

Axonics Reports First Quarter 2023 Financial Results

May 1, 2023, 4:01 PM EDT - 2 years ago

Axonics Reports First Quarter 2023 Financial Results

Axonics to Participate in Upcoming Investor Conferences

Apr 25, 2023, 6:00 AM EDT - 2 years ago

Axonics to Participate in Upcoming Investor Conferences

Axonics Acquires Technology to Facilitate Easier and Faster Placement of Implantable Leads for Sacral Neuromodulation

Apr 24, 2023, 6:00 AM EDT - 2 years ago

Axonics Acquires Technology to Facilitate Easier and Faster Placement of Implantable Leads for Sacral Neuromodulation

Axonics to Report First Quarter 2023 Financial Results on May 1

Apr 10, 2023, 6:00 AM EDT - 2 years ago

Axonics to Report First Quarter 2023 Financial Results on May 1

Axonics Ranked No. 2 on the Financial Times 2023 List of the Fastest Growing Companies in the Americas

Mar 29, 2023, 6:00 AM EDT - 2 years ago

Axonics Ranked No. 2 on the Financial Times 2023 List of the Fastest Growing Companies in the Americas

Axonics to Participate in the SUFU 2023 Winter Meeting

Mar 7, 2023, 6:00 AM EST - 2 years ago

Axonics to Participate in the SUFU 2023 Winter Meeting

Axonics, Inc. (AXNX) Q4 2022 Earnings Call Transcript

Mar 1, 2023, 10:59 PM EST - 2 years ago

Axonics, Inc. (AXNX) Q4 2022 Earnings Call Transcript

Axonics Reports Fourth Quarter and Fiscal Year 2022 Financial Results

Mar 1, 2023, 4:01 PM EST - 2 years ago

Axonics Reports Fourth Quarter and Fiscal Year 2022 Financial Results

Axonics to Report Fourth Quarter 2022 Financial Results on March 1

Feb 8, 2023, 4:30 PM EST - 2 years ago

Axonics to Report Fourth Quarter 2022 Financial Results on March 1

xMonti
xMonti Jan. 6 at 10:47 PM
$NARI After $AXNX , this was on radar. Looking at current GLP-1 demand , $VKTX $ALT
0 · Reply
NVDAMillionaire
NVDAMillionaire Dec. 1 at 2:18 PM
$AXNX Axonics, Inc. (NASDAQ:AXNX): A Pioneering Force in Bladder and Bowel Dysfunction Management https://beyondspx.com/article/axonics-inc-nasdaq-axnx-a-pioneering-force-in-bladder-and-bowel-dysfunction-management
0 · Reply
TwongStocks
TwongStocks Nov. 14 at 8:07 PM
$AXNX At a special meeting held on March 22, 2024 the shareholders of Axonics, Inc. (AXNX) approved a merger with Boston Scientific Corp (BSX) . The merger is tentatively scheduled to close prior to the market open on November 15, 2024. In anticipation of the closing, the stock will be halted immediately following the after-hours session at or around 7:50 p.m. on November 14, 2024. If the merger closes as anticipated, the stock will remain halted on the day of closing (November 15th) and will be suspended effective November 18, 2024 https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2024-557
0 · Reply
PenkeTrading
PenkeTrading Nov. 5 at 12:27 PM
I found you an Overbought RSI (Relative Strength Index) on the daily chart of Axonics Modulation Technologies Inc. Is that bullish or bearish? $AXNX #RsiOverbought #NASDAQ
1 · Reply
WeeklyTrader
WeeklyTrader Oct. 23 at 11:08 AM
Climbing higher with $AXNX! RSI: 68.7% 50-day MA: $69.34 200-day MA: $68.19
0 · Reply
WeeklyTrader
WeeklyTrader Oct. 15 at 6:09 PM
Riding the momentum wave! Buy a CALL on $AXNX at strike None! RSI: 69.78% 50-day MA: $69.13 200-day MA: $67.87
0 · Reply
WeeklyTrader
WeeklyTrader Oct. 13 at 7:44 AM
Who’s looking for the exits with $AXNX? RSI: 72.82% 50-day MA: $69.1 200-day MA: $67.83
0 · Reply
WeeklyTrader
WeeklyTrader Oct. 12 at 11:03 PM
Who's planning to sell $AXNX? RSI: 72.82% 50-day MA: $69.1 200-day MA: $67.83
0 · Reply
insiderbuyingselling
insiderbuyingselling Oct. 4 at 1:54 AM
$AXNX new insider selling: 2961 shares. http://insiderbuyingselling.com/?t=AXNX
0 · Reply
Stock_Titan
Stock_Titan Sep. 26 at 10:00 AM
$AXNX Axonics Receives Regulatory Approval for Fourth-Generation Rechargeable SNM System in Australia https://www.stocktitan.net/news/AXNX/axonics-receives-regulatory-approval-for-fourth-generation-3ovsgvazbyi0.html
0 · Reply
StockInvest_us
StockInvest_us Sep. 26 at 8:34 AM
Signal alert: $AXNX - Double Bottom https://stockinvest.us/l/TDYISiSl2O
0 · Reply
DonCorleone77
DonCorleone77 Sep. 18 at 11:08 PM
$AXNX $MDT Axonics prevails in patent infringement lawsuit with Medtronic Axonics (AXNX) announced that the jury has returned a unanimous verdict in the patent infringement lawsuit brought by Medtronic (MDT) against Axonics in U.S. District Court for the Central District of California. The jury found that Axonics does not infringe any of the three patents-in-suit. "A jury of our peers recognized that Axonics' proprietary tined lead design and temperature sensor technology is differentiated from our competitor's intellectual property," said Raymond W. Cohen, chief executive officer. "As we have said since this case was first filed in late 2019, our view is that Medtronic's lawsuit was initiated to stifle competition, limit patient and physician choice, and protect the incumbent's monopoly in sacral neuromodulation. We are very pleased with the jury's finding and continue to remain focused on fulfilling our mission of positively impacting the lives of adults with bladder and bowel dysfunction."
0 · Reply
Stock_Titan
Stock_Titan Sep. 18 at 10:59 PM
$AXNX Axonics Prevails in Patent Infringement Lawsuit with Medtronic https://www.stocktitan.net/news/AXNX/axonics-prevails-in-patent-infringement-lawsuit-with-8kt1pxdoa3dc.html
0 · Reply
StockInvest_us
StockInvest_us Sep. 10 at 11:35 PM
Signal alert: $AXNX - GoldenStar https://stockinvest.us/l/XTK7XfiU7A
0 · Reply
StockInvest_us
StockInvest_us Aug. 24 at 12:41 AM
Signal alert: $AXNX - GoldenStar https://stockinvest.us/l/8awVuuaKhq
0 · Reply
StockInvest_us
StockInvest_us Aug. 10 at 3:38 AM
Signal alert: $AXNX - GoldenStar https://stockinvest.us/l/PdSYIvpkGH
0 · Reply
epsguid
epsguid Aug. 1 at 8:08 PM
$AXNX reported earnings of $0.13, consensus was $0.08 via @eWhispers #epsbeat http://eps.sh/d/axnx
0 · Reply
Stock_Titan
Stock_Titan Aug. 1 at 8:01 PM
$AXNX Axonics Reports Second Quarter 2024 Financial Results https://www.stocktitan.net/news/AXNX/axonics-reports-second-quarter-2024-financial-4qsgjxocmn0h.html
0 · Reply
StockInvest_us
StockInvest_us Aug. 1 at 5:40 AM
Signal alert: $AXNX - GoldenStar https://stockinvest.us/l/Yy6bkR6Bzp
0 · Reply
NVDAMillionaire
NVDAMillionaire Jul. 31 at 12:06 PM
$AXNX Axonics, Inc. (NASDAQ:AXNX) – A Comprehensive Look at This Innovative Medical Technology Company http://beyondspx.com/2024/07/30/axonics-inc-nasdaqaxnx-a-comprehensive-look-at-this-innovative-medical-technology-company/
0 · Reply